PROVENTIL-HFA Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Proventil-hfa, and when can generic versions of Proventil-hfa launch?

Proventil-hfa is a drug marketed by Kindeva and is included in one NDA.

The generic ingredient in PROVENTIL-HFA is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Proventil-hfa

A generic version of PROVENTIL-HFA was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5^th, 1989.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for PROVENTIL-HFA?
What are the global sales for PROVENTIL-HFA?
What is Average Wholesale Price for PROVENTIL-HFA?

Summary for PROVENTIL-HFA

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	6
Raw Ingredient (Bulk) Api Vendors:	81
Clinical Trials:	19
Patent Applications:	5,404
DailyMed Link:	PROVENTIL-HFA at DailyMed

Drug patent expirations by year for PROVENTIL-HFA

Recent Clinical Trials for PROVENTIL-HFA

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
AstraZeneca	Phase 2
University Medical Center of Southern Nevada	N/A
West Penn Allegheny Health System	Phase 4

See all PROVENTIL-HFA clinical trials

Paragraph IV (Patent) Challenges for PROVENTIL-HFA

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
PROVENTIL-HFA	Inhalation Aerosol	albuterol sulfate	0.09 mg base per actuation	020503	1	2015-05-20

US Patents and Regulatory Information for PROVENTIL-HFA

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Kindeva	PROVENTIL-HFA	albuterol sulfate	AEROSOL, METERED;INHALATION	020503-001	Aug 15, 1996	AB1	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PROVENTIL-HFA

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Kindeva	PROVENTIL-HFA	albuterol sulfate	AEROSOL, METERED;INHALATION	020503-001	Aug 15, 1996	⤷ Sign Up	⤷ Sign Up
Kindeva	PROVENTIL-HFA	albuterol sulfate	AEROSOL, METERED;INHALATION	020503-001	Aug 15, 1996	⤷ Sign Up	⤷ Sign Up
Kindeva	PROVENTIL-HFA	albuterol sulfate	AEROSOL, METERED;INHALATION	020503-001	Aug 15, 1996	⤷ Sign Up	⤷ Sign Up
Kindeva	PROVENTIL-HFA	albuterol sulfate	AEROSOL, METERED;INHALATION	020503-001	Aug 15, 1996	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for PROVENTIL-HFA

See the table below for patents covering PROVENTIL-HFA around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
New Zealand	241170	DEVICE FOR DELIVERING AN AEROSOL HAVING A VALVE STEM PASSING THROUGH A DIAPHRAGM COMPRISING A BLEND OF THERMOPLASTIC ELASTOMER WHICH IS MORE THAN 80% ETHYLENE POLYMER BLENDS, SEALS PREPARED THEREFROM	⤷ Sign Up
Denmark	0673857		⤷ Sign Up
Australia	6665994		⤷ Sign Up
World Intellectual Property Organization (WIPO)	9211190		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for PROVENTIL-HFA

Recent Clinical Trials for PROVENTIL-HFA

Paragraph IV (Patent) Challenges for PROVENTIL-HFA

Make Better Decisions: Try a trial or see plans & pricing